Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia

Deaths caused by barbiturate overdoses have increased in the past decade, especially as a result of suicide attempts. Pentobarbitone is a central nervous system depressant used for sedation and euthanasia in veterinary medicine. However, pentobarbitone analysis is not commonly available in the hospi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thanjira Jiranantakan, Sarah Ritchie, Cristy Rowe, Jason Tran, Catherine McDonald, Santiago Vazquez, Robin Auld, Jared Brown
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	forensic sciences forensic toxicology pentobarbitone barbiturate suicide dark web toxicology testing Criminal law and procedure K5000-5582 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/0621a3c7a65749c3bfcf242ae042c63a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0621a3c7a65749c3bfcf242ae042c63a
record_format	dspace
spelling	oai:doaj.org-article:0621a3c7a65749c3bfcf242ae042c63a2021-12-01T14:40:59ZSurvival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia2096-17902471-141110.1080/20961790.2021.1975613https://doaj.org/article/0621a3c7a65749c3bfcf242ae042c63a2021-07-01T00:00:00Zhttp://dx.doi.org/10.1080/20961790.2021.1975613https://doaj.org/toc/2096-1790https://doaj.org/toc/2471-1411Deaths caused by barbiturate overdoses have increased in the past decade, especially as a result of suicide attempts. Pentobarbitone is a central nervous system depressant used for sedation and euthanasia in veterinary medicine. However, pentobarbitone analysis is not commonly available in the hospital setting; hence, its occurrence in overdoses is under-reported. Herein we describe a patient who ingested pentobarbitone obtained from the Internet with the purpose of ending his life. He became comatose and required ventilation for 6 days. While critically ill, the drug and a barbiturate test kit were found in his room at his residence. Toxicological analysis of the patient’s blood determined the presence of pentobarbitone at levels of 91, 56, and 19 mg/L at 11, 59, and 107 h after ingestion, respectively. With supportive care, the patient made a full recovery. He stated that he believed the liquid was to be pentobarbitone, and that he had received advice on its use from an online forum that he had found on a dark web marketplace. In this report, we highlight the process by which we facilitated pentobarbitone analysis with a rapid turnaround time, which helped to inform clinical management and raise awareness among clinicians. The access was made through the Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme, which is a collaborative network among the New South Wales (NSW) Ministry of Health, NSW Poisons Information Centre (PIC), and NSW Health Pathology Forensic & Analytical Science Service (FASS).Key points • We report a patient with confirmed severe pentobarbitone toxicity who developed coma, respiratory failure, barbiturate related skin and vascular manifestations who required intensive care for 6 days.• The diagnosis of pentobarbitone poisoning can be missed as it is not routinely included in Australian standard hospital urine drug screens, and it may not cross-react with phenobarbitone testing which may be more readily available. • Timely access to comprehensive toxicology testing with rapid turnaround time assists diagnosis for unknown toxicity, and enhances case management and public health interventions. • The PRISE programme in Australia is a collaboration between multiple health functional units in NSW, Australia that provides timely access to extensive toxicology testing for severe and unusual toxicity from drugs or substance-related toxicities.Thanjira JiranantakanSarah RitchieCristy RoweJason TranCatherine McDonaldSantiago VazquezRobin AuldJared BrownTaylor & Francis Grouparticleforensic sciencesforensic toxicologypentobarbitonebarbituratesuicidedark webtoxicology testingCriminal law and procedureK5000-5582Public aspects of medicineRA1-1270ENForensic Sciences Research, Vol 6, Iss 3, Pp 231-236 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	forensic sciences forensic toxicology pentobarbitone barbiturate suicide dark web toxicology testing Criminal law and procedure K5000-5582 Public aspects of medicine RA1-1270
spellingShingle	forensic sciences forensic toxicology pentobarbitone barbiturate suicide dark web toxicology testing Criminal law and procedure K5000-5582 Public aspects of medicine RA1-1270 Thanjira Jiranantakan Sarah Ritchie Cristy Rowe Jason Tran Catherine McDonald Santiago Vazquez Robin Auld Jared Brown Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia
description	Deaths caused by barbiturate overdoses have increased in the past decade, especially as a result of suicide attempts. Pentobarbitone is a central nervous system depressant used for sedation and euthanasia in veterinary medicine. However, pentobarbitone analysis is not commonly available in the hospital setting; hence, its occurrence in overdoses is under-reported. Herein we describe a patient who ingested pentobarbitone obtained from the Internet with the purpose of ending his life. He became comatose and required ventilation for 6 days. While critically ill, the drug and a barbiturate test kit were found in his room at his residence. Toxicological analysis of the patient’s blood determined the presence of pentobarbitone at levels of 91, 56, and 19 mg/L at 11, 59, and 107 h after ingestion, respectively. With supportive care, the patient made a full recovery. He stated that he believed the liquid was to be pentobarbitone, and that he had received advice on its use from an online forum that he had found on a dark web marketplace. In this report, we highlight the process by which we facilitated pentobarbitone analysis with a rapid turnaround time, which helped to inform clinical management and raise awareness among clinicians. The access was made through the Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme, which is a collaborative network among the New South Wales (NSW) Ministry of Health, NSW Poisons Information Centre (PIC), and NSW Health Pathology Forensic & Analytical Science Service (FASS).Key points • We report a patient with confirmed severe pentobarbitone toxicity who developed coma, respiratory failure, barbiturate related skin and vascular manifestations who required intensive care for 6 days.• The diagnosis of pentobarbitone poisoning can be missed as it is not routinely included in Australian standard hospital urine drug screens, and it may not cross-react with phenobarbitone testing which may be more readily available. • Timely access to comprehensive toxicology testing with rapid turnaround time assists diagnosis for unknown toxicity, and enhances case management and public health interventions. • The PRISE programme in Australia is a collaboration between multiple health functional units in NSW, Australia that provides timely access to extensive toxicology testing for severe and unusual toxicity from drugs or substance-related toxicities.
format	article
author	Thanjira Jiranantakan Sarah Ritchie Cristy Rowe Jason Tran Catherine McDonald Santiago Vazquez Robin Auld Jared Brown
author_facet	Thanjira Jiranantakan Sarah Ritchie Cristy Rowe Jason Tran Catherine McDonald Santiago Vazquez Robin Auld Jared Brown
author_sort	Thanjira Jiranantakan
title	Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia
title_short	Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia
title_full	Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia
title_fullStr	Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia
title_full_unstemmed	Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia
title_sort	survival after pentobarbitone overdose confirmed through prescription, recreational and illicit substance evaluation (prise) programme in australia
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/0621a3c7a65749c3bfcf242ae042c63a
work_keys_str_mv	AT thanjirajiranantakan survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT sarahritchie survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT cristyrowe survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT jasontran survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT catherinemcdonald survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT santiagovazquez survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT robinauld survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia AT jaredbrown survivalafterpentobarbitoneoverdoseconfirmedthroughprescriptionrecreationalandillicitsubstanceevaluationpriseprogrammeinaustralia
_version_	1718404975874277376

Survival after pentobarbitone overdose confirmed through Prescription, Recreational and Illicit Substance Evaluation (PRISE) programme in Australia

Ejemplares similares